Polarity Bio

Evolving perceptions of what is possible in the wound care market required a new brand identity and strategic positioning for this biotech innovator.

CASE STUDY  /  POLARITY BIO

Polarity Bio’s breakthrough autologous wound-healing product has the potential to revolutionize the standard of care and vastly improve patient care and experiences.

The visionary leadership, exquisite science, and exceptional team had more in store than the market understood or expected. We worked in partnership with their team to invigorate the Polarity brand from offering a single product to a sophisticated, growing biologic company with a robust pipeline.

Services

Brand Strategy

Brand Positioning

Brand Visual Identity Extension + Guidelines

Corporate Presentation Narrative + Design

The new Polarity brand began with the development of evolved brand foundations – statements to ground the organization and guide it as its north star.

Brand Strategy

A webpage with a dark background featuring an abstract blue and purple design. The text says: "Our Vision: To create a world where wound healing is imminently possible and expected in every patient." Below, there are sections titled 'Our Purpose' and 'Core Values' with the text: 'Pursue the knowledge and innovations that make tissue regeneration possible.' and 'We are Innovative, Relentless, Accessible, Rigorous, and Collaborative.'

With its foundation in place, we moved to position the brand to its stakeholders, shifting perspectives by focusing the narrative toward Polarity’s exquisite science and impressive data.

Brand POSITIONING

A new, sophisticated mark and visual identity system sends a strong signal to the market. With smart design,
the science narrative unfolds in visual stories to newly-engaged audiences.

Brand VISUAL IDENTITY

Abstract design of six circles in purple, blue, and white on a dark background.

Close-up of a smartphone screen displaying the text "Polarity Bio" and the phrase "Harnessing Technology to Unleash the Innate" with a background of abstract blue patterns.

Microscopic view of human skin tissue, showing epidermis with hair follicles and underlying dermis, stained with hematoxylin and eosin, with a digital blue filter overlay.

A close-up image of purple, blue, and pink glittery textured surface.

Close-up of blue coral with overlaid text about activating the body's natural regenerative power to self-heal.

Colorful gradient background with shades of blue, purple, and cyan.

A person sitting on a couch with one foot on the floor, and their ankle wrapped in a medical bandage, indicating an injury.

Text overlay stating '2X improvement in wound closure vs. current standard-of-care measurements' on a background of blue glowing particles.

A large flock of birds flying in the sky during sunset, forming a dense, swirling pattern.

A person with a bandaged foot being attended to by a healthcare professional wearing blue gloves.

Close-up image of soap bubbles with a vibrant blue background. Overlaid white text states: "Regenerates full-thickness, functional skin with all layers and appendages."

Three Polarity Bio water bottles with different label designs on a blue background.

A man wearing a blue Patagonia quilted jacket with logos for Polarity Bio and Patagonia on a purple background.

Open brochure spread with a dark blue cover and a blue and black marbled interior, featuring text about PolarityBio, a biotech company specializing in autologous cell therapy and wound care solutions.

Close-up of a man wearing a black jacket with logos that say "Polarity Bio" and a small chameleon graphic.

Organizational chart titled 'Science and Medicine Driven Management' showing photos and titles of executives and board members at Polarity Bio, including CEO John Stetson, COO Nikola Sokpo, MD, PhD, President Ned Swanson, MD, and others, with a list of board members and advisors on the right.

Infographic with headline 'Rising Need With Little Meaningful Innovation Has Fossilized Wound Care' and three sections. The first section discusses unmet need of serious wounds, highlighting 40 years, 40 million wounds, and US$100 billion costs. The second section covers patient journey for wounds, stating 35% of patients don't heal or get amputated after 40 years, with statistics on healing rates and amputation risks. The third section shows under-appreciated mortality burden, comparing 5-year mortality rates for wounds and cancer, with a bar chart illustrating rates for various wound types and cancer.

Slide showing potential patient numbers for SkinTE across different wound types, including diabetic foot ulcers, venous leg ulcers, pressure injuries, trauma wounds, and burns. It highlights the overlapping causes, biology, and challenges of these wound types, such as low blood flow, congestion, and pressure, along with how SkinTE addresses these issues.

An infographic titled '2020 RCT of SkinTE - Phase 2 Wagner 1 DFU'. It includes a study design timeline, objectives, primary outcome measure, closure parameters, and patient information. The timeline shows patient consent, randomization, weekly visits, wound evaluation, week 12, and primary endpoints. The primary outcome is the percentage of wounds closed at 12 weeks. The closure parameters involve initial site, validated closure, and wound stability. The study involved 100 subjects across 13 US sites with a 12-week duration, comparing SkinTE plus SOC versus SOC alone for Wagner 1 diabetic foot ulcers.

WRAP-UP

Polarity Bio continues to build upon the strength of their revolutionary science. Their inaugural product recently received breakthrough designation from the FDA in the early stages of their Phase 3 Clinical Trial. We look forward to much more from this visionary team as they reshape the landscape of wound care, and work to make wound healing imminently possible and expected for every patient.

/